new glp-1 drugs The Revolution: From Diabetes and Obesity to Alzheimer's and PCOS New research is taking a

Finally, a prospective cohort study including 7438 mother-child pairs, investigated whether a maternal anti-inflammatory diet reduced the risk of prenatal environmental adversity (PEA)-induced neurodevelopmental delay

Samyshkin Y, Guillermin AL, Best JH, Brunell SC, Lloyd A

IBD and inflammatory bowel conditions Crohn's disease and ulcerative colitis timing: Most IBD patients report morning urgency/diarrhea Morning symptoms = cytokine-driven inflammation Nocturnal gut healing critical for remission Consider timing based on symptom pattern Morning urgency/diarrhea (most common): Best approach: Evening dosing night before Dose 9-10 PM effects peak overnight prevents AM flare Supports nocturnal healing simultaneously Reduces morning urgency/diarrhea Many report this most effective All-day IBD symptoms: Best approach: Split dosing (AM + PM) Morning dose: 250-500mcg before breakfast Evening dose: 250-500mcg before bed Provides 24-hour coverage Maximum anti-inflammatory effect Flare management timing: Acute flare: Consider 3x daily dosing temporarily Morning, midday, evening dosing Short-term (1-2 weeks) to control flare Then back to 1-2x daily maintenance Higher doses during acute phases Maintenance remission timing: Once daily sufficient for many in remission Evening dosing supports healing Prevents morning breakthrough symptoms Less aggressive than split dosing Cost-effective maintenance KPV + other IBD peptides: Learn about peptides for gut health stacking

Meta 13:674

B., Gregoire, F

Moore said primary care providers who arent familiar with prescribing GLP-1 medications may struggle at first